Latest Regulatory Progress News

Viking Mines Limited has reported successful results from an expanded ground gravity survey at its Linka Tungsten Project in Nevada, identifying numerous new high gravity anomalies that correlate with known mineralisation and concealed targets beneath volcanic cover. These findings support the company’s plan to commence drilling in the June quarter.

TMK Energy Limited (ASX: TMK) reported a 48% increase in average daily gas production at its Gurvantes XXXV Coal Seam Gas Project in March 2026, achieving a new peak daily rate before temporarily curtailing output for operational safety. The company also secured a Memorandum of Understanding with Mongolia’s regulator to facilitate power generation and progress towards an exploitation license.

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

Imricor Medical Systems has submitted its NorthStar Mapping System for FDA pediatric label expansion, aiming to accelerate adoption in over 250 US children’s hospitals and broaden its commercial footprint.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

Capricorn Metals delivered 30,358 ounces of gold in Q3 FY26 at the Karlawinda Gold Project, aligning with its mine plan and progressing the Karlawinda Expansion Project with peak construction activity.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

Infini Resources has finalised drill targets for a maiden 2,500m diamond drilling campaign at its Reynolds Lake and Reitenbach Lake uranium projects, aiming to unlock the potential of a large, underexplored uranium system on the eastern margin of the Athabasca Basin.

Papua New Guinea’s Conservation and Environment Protection Authority has approved an updated Environment Permit for Geopacific Resources’ Woodlark Gold Project, enabling increased throughput and signalling strong government backing ahead of a key feasibility study.

Alterity Therapeutics has secured encouraging regulatory feedback from the FDA on its ATH434 Phase 3 program for Multiple System Atrophy, marking a critical step towards pivotal trial initiation.

Native Mineral Resources has successfully poured 560 ounces of gold doré at its Blackjack plant and is on track to begin mining at Podosky in April, advancing multiple projects in Queensland.

Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.